Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals, Ltd., an Australian biopharmaceutical company, is developing Pentosan Polysulfate Sodium (PPS) for the treatment of musculoskeletal disease-related pain caused by injury, inflammation, aging, degenerative diseases, infection, or genetic predisposition.